Literature DB >> 25966738

Fasting plasma triglyceride concentration: A possible approach to identify increased risk of statin-induced type 2 diabetes.

Ki-Chul Sung1, Gerald Reaven2.   

Abstract

AIM: To evaluate the hypothesis that measurement of fasting plasma triglyceride concentration identifies individuals at enhanced risk of statin-induced type 2 diabetes mellitus.
METHODS: A retrospective analysis of data collected from routine health examinations in non-diabetic, East Asian individuals (n = 5790) with low-density lipoprotein cholesterol concentrations of ⩾3.4 mmol/L. Subjects were stratified into those with or without a triglyceride concentration of ⩾1.7 mmol/L, and comparisons made of risk factors for type 2 diabetes mellitus.
RESULTS: Approximately 40% of men and 20% of women with elevations of both low-density lipoprotein cholesterol and triglyceride concentrations were more insulin resistant (homeostatic model assessment of insulin resistance), associated with higher plasma concentrations of HbA1c, glucose and insulin.
CONCLUSION: Apparently, healthy, non-diabetic East Asian men and women with combined elevations of low-density lipoprotein cholesterol and triglyceride concentrations are glucose intolerant and insulin resistant, and thereby at enhanced risk of type 2 diabetes mellitus. Measurement of plasma triglyceride concentration can identify within a hypercholesterolemic population a subset of individuals at enhanced risk of statin-induced type 2 diabetes mellitus.
© The Author(s) 2015.

Entities:  

Keywords:  Statins; cardiovascular disease; hypercholesterolemia; insulin resistance; statin-induced diabetes; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 25966738     DOI: 10.1177/1479164115584275

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  1 in total

1.  Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: a prospective study with 8-year follow-ups in two cohorts.

Authors:  Jing Zhao; Yuan Zhang; Fengjiang Wei; Jiani Song; Zhi Cao; Chen Chen; Kai Zhang; Shuzhi Feng; Yaogang Wang; Wei-Dong Li
Journal:  J Transl Med       Date:  2019-12-03       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.